Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY
Phase 2
- Conditions
- Diabetes Mellitus
- Interventions
- Drug: Saline (placebo)Drug: LABR-312
- First Posted Date
- 2016-01-05
- Last Posted Date
- 2018-01-11
- Lead Sponsor
- BIOrest Ltd.
- Target Recruit Count
- 270
- Registration Number
- NCT02645799
- Locations
- 🇮🇱
Kaplan Medical Center, Rehovot, Israel
Biorest Liposomal Alendronate With Stenting sTudy (BLAST)
Phase 2
Completed
- Conditions
- Coronary Artery Stenosis
- Interventions
- Drug: Liposomal AlendronateDrug: Saline infusion (placebo)
- First Posted Date
- 2008-08-21
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- BIOrest Ltd.
- Target Recruit Count
- 226
- Registration Number
- NCT00739466
- Locations
- 🇮🇱
Hillel Yaffe Medical Center, Hadera, Israel
🇮🇱Bnei Zion Medical Center, Haifa, Israel
🇮🇱Rambam Health Care Campus, Haifa, Israel
News
No news found